%0 Journal Article
%T Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
%A Lydia Lee and Adele K. Fielding
%J Clinical Medicine Insights: Oncology
%D 2012
%I 
%R 10.4137/CMO.S7262
%X Acute lymphoblastic leukemia (ALL) treatment regimes are amongst the longest, most intensive and complex used in hemato-oncology. Despite this, while treatment of pediatric ALL is a success story, we are far from being able to ensure a durable response in adult ALL. This is not due to failure of induction therapy as a complete remission (CR) is achieved in over 90% of patients. However the challenge remains in ensuring a sustained remission. Furthermore in the face of relapsed disease, salvage therapies currently offer a poor chance of a good outcome. This article reviews the novel agents which show the most promise in the treatment of adult ALL.
%U http://www.la-press.com/emerging-pharmacotherapies-for-adult-patients-with-acute-lymphoblastic-article-a2999